How semaglutide affects muscle mass during weight loss

Step 1: Understanding why some muscle loss happens on semaglutide

When the body loses weight, it draws on a mixture of fat stores and lean tissue, muscle, bone and water. This is not a flaw unique to semaglutide; it occurs on low-calorie diets, after bariatric surgery and during almost any sustained calorie deficit. The proportion of lean tissue lost tends to be higher when weight comes off quickly or when protein intake is low.

Semaglutide, the active ingredient in Wegovy, works partly by slowing gastric emptying and reducing appetite through GLP-1 receptor activation. That appetite suppression is effective, but it also means many people eat considerably less than before, sometimes dropping protein intake without realising it. The body then has less of the raw material it needs to maintain and repair muscle fibres.

There is no strong evidence that semaglutide damages muscle tissue directly, and if you want to understand how semaglutide affects muscle mass in more depth, the mechanism is indirect: a meaningful calorie deficit, sustained over months, with appetite suppression that may work against deliberate high-protein eating. The NHS medicines page for semaglutide covers the medicine's general effects, and the STEP 1 trial published in the New England Journal of Medicine reported approximately 15% average body-weight reduction at 68 weeks, a significant change that inevitably involves some lean tissue.

The practical upshot: muscle loss during semaglutide treatment is real, it is not catastrophic for most people, and it is substantially modifiable with the right approach.

Step 2: What the numbers actually look like

Body-composition data from weight-loss trials, including those involving GLP-1 medicines, typically show that lean mass accounts for roughly a quarter to a third of total weight lost. Some analyses put the figure higher. This sounds like a lot until you consider that someone losing 15kg might lose 10–11kg of fat and 4–5kg of lean tissue, which includes fluid and connective tissue alongside muscle protein itself, not just the contractile fibres people worry about.

Absolute muscle mass often falls; relative muscle mass as a proportion of body weight can stay broadly stable or even improve, because total body weight drops alongside it. Functional strength, which is what most people care about day-to-day, appears to hold up reasonably well in people who stay physically active during treatment. A question our prescribers hear regularly is whether continuing treatment is worth it given this trade-off, the clinical consensus, reflected in NICE's appraisal of semaglutide for weight management (TA875), is that the metabolic and cardiovascular benefits of meaningful weight loss outweigh the lean-tissue cost for eligible adults, particularly those with weight-related health conditions.

For a broader look at how body composition changes on this medicine, the evidence on Wegovy and muscle mass goes into further detail on the trial data.

Step 3: Practical strategies that the evidence supports

Two interventions consistently reduce lean tissue loss during weight loss: adequate protein intake and resistance exercise. Neither is glamorous, but both are genuinely effective.

Protein targets during active weight loss are typically set higher than everyday population recommendations, many dietitians working with people on GLP-1 treatment suggest aiming for around 1.2–1.6g of protein per kilogram of body weight daily, though personal targets should come from your own clinical team. The challenge is that semaglutide's appetite-suppressing effect can make hitting that target feel difficult, especially in the first weeks. Spacing protein across three or four smaller meals, prioritising high-quality sources (eggs, fish, legumes, Greek yoghurt, lean meat), and treating protein as a non-negotiable part of each meal rather than an afterthought all help.

Resistance training (weightlifting, bodyweight exercises, resistance bands) sends a signal to the body that muscle tissue is needed and should be preserved. Even two sessions a week produces a meaningful protective effect. Aerobic exercise is valuable for cardiovascular health but does less to preserve muscle specifically.

Planning both takes a little thought. If you tend to order your treatment at the start of the month, it is worth booking those gym sessions or planning higher-protein meal days at the same time, so the habits run in parallel from the start rather than being added as an afterthought weeks in. The weight-loss treatment overview at nume includes further context on the lifestyle components that sit alongside medical treatment.

Step 4: When to raise muscle concerns with your prescriber

Most people on semaglutide notice changes in how they feel physically, some report feeling weaker early on, particularly if appetite suppression leads to significant under-eating in the first few months. This is worth mentioning at your next review rather than managing alone. A prescriber can consider whether your dose trajectory is appropriate, whether a dietitian referral would help, or whether the treatment plan needs adjusting.

Red flags worth raising sooner: significant, rapid loss of strength that affects daily function; difficulty eating enough to sustain basic activity; or any sign that overall nutrition is becoming seriously compromised. These are not common, but they are clinical matters rather than things to push through.

For people already thinking about whether semaglutide is right for them given this concern, the clinical picture on semaglutide and lean tissue reduction covers the prescribing context in more detail. Questions about how changes during treatment affect other aspects of health (sleep, for instance) also come up regularly, and the evidence there is similarly nuanced.

Treatment is a prescription-only medicine reviewed individually. If you would like to discuss your situation with a GPhC-registered prescriber, you can check your eligibility and start a free consultation, a real clinician reads your answers the same day.